CEO Shailesh Jejurikar to lead Procter & Gamble (NYSE: PG) board as chairman
Rhea-AI Filing Summary
The Procter & Gamble Company announced a planned leadership transition. Executive Chairman Jon R. Moeller will retire as Executive Chairman and as a member of the Board of Directors effective July 31, 2026, and will retire from the company on August 14, 2026, after 38 years of service.
Shailesh G. Jejurikar, currently President, Chief Executive Officer and a director, has been appointed Chairman of the Board effective August 1, 2026, in addition to his existing responsibilities, to serve at the pleasure of the Board. The non-employee directors also reappointed Joseph Jimenez as the Board’s independent Lead Director. A news release dated July 29, 2026 announcing these changes is furnished as an exhibit. Procter & Gamble notes its portfolio of leading consumer brands and operations in approximately 70 countries worldwide.
Positive
- None.
Negative
- Executive Chairman retirement: Jon R. Moeller will step down from the Board on July 31, 2026 and retire from Procter & Gamble on August 14, 2026 after 38 years, marking a leadership transition at the top of the company.
Insights
Analyzing...
8-K Event Classification
3 items: 5.02, 7.01, 9.01
3 items
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Item 7.01
Regulation FD Disclosure
Disclosure
Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Key Figures
Board retirement effective date: July 31, 2026
Company retirement date: August 14, 2026
Chairman appointment effective date: August 1, 2026
+2 more
5 metrics
Board retirement effective date
July 31, 2026
Jon R. Moeller retires as Executive Chairman and Board member effective July 31, 2026.
Company retirement date
August 14, 2026
Jon R. Moeller will retire from Procter & Gamble on August 14, 2026.
Chairman appointment effective date
August 1, 2026
Shailesh G. Jejurikar is appointed Chairman of the Board effective August 1, 2026.
Years of service
38 years
Jon R. Moeller has served Procter & Gamble for 38 years in multiple senior roles.
Countries of operation
approximately 70 countries
Procter & Gamble’s community includes operations in approximately 70 countries worldwide.
Key Terms
Executive Chairman, Lead Director, Regulation FD Disclosure, forward-looking statements, +1 more
5 terms
Executive Chairman financial
"Jon R. Moeller, Executive Chairman of the Board, will retire"
An executive chairman is the board leader who also takes an active role in running the company, combining oversight of the board with hands-on involvement in strategy and major decisions. For investors, this matters because it concentrates influence in one person—like a team captain who both sets the game plan and plays on the field—so their judgment can speed decisions but also increases governance and succession risk that can affect stock value.
Lead Director financial
"the Board reappointed Joseph Jimenez as the Board’s independent Lead Director"
A lead director is a board member chosen by other independent directors to coordinate the board’s independent oversight of company management, acting like a team captain or referee who organizes meetings, leads discussions without the CEO present, and serves as a primary contact between independent directors and company leadership. Investors care because a strong lead director helps prevent conflicts of interest, improves decision-making and accountability, and signals that the board is actively watching how management runs the business.
Regulation FD Disclosure regulatory
"The Company is furnishing the information under this item, including Exhibit 99.1, pursuant to Item 7.01, Regulation FD Disclosure"
Regulation FD disclosure requires public companies to share important, market-moving information with everyone at the same time instead of tipping off analysts or large investors first. Think of it as making sure all players on a field hear the same announcement simultaneously; that fairness helps investors trust that stock prices reflect the same information and reduces the risk of sudden, unfair trading advantages or regulatory penalties for selective leaks.
forward-looking statements regulatory
"Certain statements in this release, other than purely historical information, are forward-looking statements"
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.
Private Securities Litigation Reform Act of 1995 regulatory
"within the meaning of the Private Securities Litigation Reform Act of 1995"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What leadership changes did Procter & Gamble (PG) announce on July 29, 2026?
Procter & Gamble announced that Executive Chairman Jon R. Moeller will retire and that President and CEO Shailesh G. Jejurikar has been appointed Chairman of the Board effective August 1, 2026, while Joseph Jimenez was reappointed as independent Lead Director.
When will Jon R. Moeller retire from Procter & Gamble (PG) and its Board?
Jon R. Moeller will retire as Executive Chairman and director effective July 31, 2026, and will remain with Procter & Gamble until August 14, 2026, when he retires from the company after 38 years of service.
What roles will Shailesh G. Jejurikar hold at Procter & Gamble (PG)?
Shailesh G. Jejurikar will serve as President and Chief Executive Officer and, effective August 1, 2026, also as Chairman of the Board. He is already a member of the Board and will hold these leadership roles concurrently.
Who is the independent Lead Director on Procter & Gamble’s (PG) Board?
Procter & Gamble’s non-employee directors have reappointed Joseph Jimenez as the Board’s independent Lead Director. This role provides independent leadership on the Board alongside the Chairman and supports governance and oversight of the company’s management.
In how many countries does Procter & Gamble (PG) operate and what brands does it offer?
Procter & Gamble operates in approximately 70 countries and markets a portfolio of brands including Pampers, Tide, Ariel, Gillette, Head & Shoulders, Olay, Oral-B and others, serving consumers worldwide with a range of household and personal care products.
What information did Procter & Gamble (PG) provide under Regulation FD in this report?
Procter & Gamble furnished, under a Regulation FD Disclosure item, a news release dated July 29, 2026 as Exhibit 99.1 that announces Jon Moeller’s retirement and Shailesh Jejurikar’s appointment as Chairman of the Board.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________________________________
FORM 8-K
___________________________________
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (date of earliest event reported): July 29, 2026
___________________________________
(Exact name of registrant as specified in its charter)
___________________________________
(State or other jurisdiction of incorporation or organization) | (Commission File Number) | (I.R.S. Employer Identification Number) | ||||||
(Address of principal executive offices and zip code) | ||||||||
( | ||||||||
(Registrant's telephone number, including area code) | ||||||||
___________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |||||
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |||||
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |||||
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | |||||
Securities registered pursuant to Section 12(b) of the Act: | ||||||||
Title of each class | Trading Symbol | Name of each exchange on which registered | ||||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 12b-2 of the Exchange Act.
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS
On July 29, 2026, The Procter & Gamble Company (the "Company") announced that Jon R. Moeller, Executive Chairman of the Board, will retire from his position as Executive Chairman and as a member of the Board of Directors (“the Board”), effective July 31, 2026. Mr. Moeller will remain with the Company through August 14, 2026, when he will retire from the Company.
The Company also announced that Shailesh G. Jejurikar, currently President and Chief Executive Officer and a member of the Board, has been appointed Chairman of the Board, in addition to his current responsibilities, effective August 1, 2026, to serve at the pleasure of the Board.
In addition, the non-employee Directors of the Board reappointed Joseph Jimenez as the Board’s independent Lead Director.
The Company is filing the information under this item pursuant to Item 5.02, "Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers."
ITEM 7.01 REGULATION FD DISCLOSURE
The Company issued a news release on July 29, 2026, announcing Mr. Moeller’s retirement and Mr. Jejurikar’s appointment. A copy of this news release is furnished as Exhibit 99.1
The Company is furnishing the information under this item, including Exhibit 99.1, pursuant to Item 7.01, "Regulation FD Disclosure."
ITEM 9.01 - FINANCIAL STATEMENTS AND EXHIBITS
Exhibit No. | Description | |||||||
99.1 | Dividend News Release by The Procter & Gamble Company dated July 29, 2026. | |||||||
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | |||||||
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized on this 29th day of July, 2026.
THE PROCTER & GAMBLE COMPANY | |||||
By: | /s/ Sandra T. Lane | ||||
Name: | Sandra T. Lane | ||||
Title: | Assistant Secretary | ||||
INDEX TO EXHIBIT(S)
99.1 - Executive Changes News Release by The Procter & Gamble Company dated July 29, 2026.
| News Release | The Procter & Gamble Company | |||||||||||||
| One P&G Plaza | ||||||||||||||
| Cincinnati, OH 45202 | ||||||||||||||
SHAILESH JEJURIKAR APPOINTED CHAIRMAN OF P&G BOARD OF DIRECTORS
Executive Chairman Jon Moeller to Retire
CINCINNATI, July 29, 2026 - The Procter & Gamble Company (NYSE:PG) today announced that Shailesh Jejurikar has been appointed Chairman of the Board, effective August 1, 2026. Jejurikar assumes the position in addition to his role as President and Chief Executive Officer. Jon Moeller, Executive Chairman, will retire from the Board effective July 31, 2026, and from P&G effective August 14, 2026.
“I want to thank Jon for his many years of tireless and steady leadership at P&G, having served in key roles including Executive Chairman, Chief Executive Officer, Chief Operating Officer, and Chief Financial Officer throughout his 38 years of dedicated service to the company,” said Mr. Jejurikar. “Jon’s strategic vision has been instrumental in shaping the company P&G is today, and we have benefited from his unwavering courage and his profound care for this institution and its people.”
Mr. Jejurikar joined P&G in 1989. He has been a member of P&G’s global leadership team since 2014, holding various senior leadership roles across categories, sectors and regions. He has helped build several of P&G’s core businesses, including global Fabric Care and Home Care, in regions such as North America, Europe, Asia and Latin America. He has also helped lead the development of the Company’s renewed strategies and operational results across the Supply Chain, Information Technology and Global Business Services.
About Procter & Gamble
P&G serves consumers around the world with one of the strongest portfolios of trusted, quality, leadership brands, including Always®, Ambi Pur®, Ariel®, Bounty®, Charmin®, Crest®, Dawn®, Downy®, Fairy®, Febreze®, Gain®, Gillette®, Head & Shoulders®, Lenor®, Olay®, Oral-B®, Pampers®, Pantene®, SK-II®, Tide®, Vicks®, and Whisper®. The P&G community includes operations in approximately 70 countries worldwide. Please visit https://www.pg.com for the latest news and information about P&G and its brands. For other P&G news, visit us at https://www.pg.com/news.
# # #
P&G Media Contacts:
Damon Jones, 513.983.0190, mediarelations@shared.pg.com
P&G Investor Relations Contact:
John Chevalier, 513.983.9974
About Procter & Gamble
P&G serves consumers around the world with one of the strongest portfolios of trusted, quality, leadership brands, including Always®, Ambi Pur®, Ariel®, Bounty®, Charmin®, Crest®, Dawn®,
Downy®, Fairy®, Febreze®, Gain®, Gillette®, Head & Shoulders®, Lenor®, Olay®, Oral-B®, Pampers®, Pantene®, SK-II®, Tide®, Vicks®, and Whisper®. The P&G community includes operations in approximately 70 countries worldwide. Please visit https://www.pg.com for the latest news and information about P&G and its brands. For other P&G news, visit us at https://www.pg.com/news.
# # #
P&G Media Contacts:
Damon Jones, 513.983.0190, mediarelations@shared.pg.com
P&G Investor Relations Contact:
John Chevalier, 513.983.9974
Forward-Looking Statements
Certain statements in this release, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives and expected operating results, and the assumptions upon which those statements are based, are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements generally are identified by the words "believe," "project," "expect," "anticipate," "estimate," "intend," "strategy," "future," "opportunity," "plan," "may," "should," "will," "would," "will be," "will continue," "will likely result" and similar expressions. Forward-looking statements are based on current expectations and assumptions, which are subject to risks and uncertainties that may cause results to differ materially from those expressed or implied in the forward-looking statements. We undertake no obligation to update or revise publicly any forward-looking statements, whether because of new information, future events or otherwise, except to the extent required by law.
Risks and uncertainties to which our forward-looking statements are subject include, without limitation: (1) the ability to successfully manage global financial risks, including foreign currency fluctuations, changes in global interest rates and rate differentials, currency exchange, pricing controls or tariffs; (2) the ability to successfully manage local, regional or global economic volatility, including reduced market growth rates, and to generate sufficient income and cash flow to allow the Company to effect the expected share repurchases and dividend payments; (3) the ability to successfully manage uncertainties related to changing political and geopolitical conditions and potential implications such as exchange rate fluctuations, market contraction, boycotts, variability and unpredictability in trade relations, sanctions, tariffs or other trade controls; (4) the ability to manage disruptions in credit markets or to our banking partners or changes to our credit rating; (5) the ability to maintain key manufacturing and supply arrangements (including execution of supply chain optimizations and sole supplier and sole manufacturing plant arrangements) and to manage disruption of business due to various factors, including ones outside of our control, such as natural disasters, conflicts or acts of war (such as the conflict in the Middle East), terrorism or disease outbreaks; (6) the ability to successfully manage cost fluctuations and pressures, including prices of commodities and raw materials and costs of labor, transportation, energy, pension and healthcare; (7) the ability to compete with our local and global competitors in new and existing sales channels, including by successfully responding to competitive factors such as prices, promotional incentives and trade terms for products; (8) the ability to manage and maintain key customer relationships; (9) the ability to protect our reputation and brand equity by successfully managing real or perceived issues, including concerns about safety, quality, ingredients, efficacy, packaging content, supply chain practices, social or environmental practices or similar matters that may arise; (10) the ability to successfully manage the financial, legal, reputational and operational risk associated with third-party relationships, such as our suppliers, contract manufacturers, distributors, contractors and external business partners; (11) the ability to rely on and maintain key company and third-party information and operational technology systems, networks and services and maintain the security and functionality of such systems, networks and services and the data contained therein; (12) the ability to successfully manage the demand, supply and operational challenges, as well as governmental responses or mandates, associated with a
disease outbreak, including epidemics, pandemics or similar widespread public health concerns; (13) the ability to stay on the leading edge of innovation, obtain necessary intellectual property protections and successfully respond to changing consumer habits, evolving digital marketing and selling platform requirements and technological advances attained by, and patents granted to, competitors; (14) the ability to successfully manage our ongoing acquisition, divestiture and joint venture activities, in each case to achieve the Company’s overall business strategy and financial objectives, without impacting the delivery of base business objectives; (15) the ability to successfully achieve productivity improvements and cost savings and manage ongoing organizational changes while successfully identifying, developing and retaining key employees, including in key growth markets where the availability of skilled or experienced employees may be limited; (16) the ability to successfully manage current and expanding regulatory and legal requirements and matters (including, without limitation, those laws, regulations, policies and related interpretations involving product liability, product and packaging composition, manufacturing processes, intellectual property, labor and employment, antitrust, privacy, cybersecurity, data protection and data transfers, artificial intelligence, tax, the environment, due diligence, risk oversight, accounting and financial reporting) and to resolve new and pending matters within current estimates; (17) the ability to manage changes in applicable tax laws and regulations; and (18) the ability to continue delivering progress towards our environmental sustainability ambitions. For additional information concerning factors that could cause actual results and events to differ materially from those projected herein, please refer to our most recent 10-K, 10-Q and 8-K reports.